series-c-plus
Stage
1
Investors
About
Acadia Pharmaceuticals develops and commercializes novel therapies for neurological disorders and rare diseases, focusing on treating Parkinson's Disease Psychosis, Rett Syndrome, and Alzheimer's Disease Psychosis.
Explore Acadia Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.